Can Uncontrolled AI Use Increase Manuscript Rejection Risk?
With the widespread adoption of artificial intelligence tools, AI use in preparing academic texts has increased. However, uncontrolled use carries risks that can negatively impact a manuscript's publication process.
Risks of AI-Generated Texts
Texts generated without expert oversight may exhibit superficiality, lack of context, and inconsistency. Such issues can make it difficult to meet reviewers' scientific quality expectations.
Disconnection Between Methodology, Findings, and Discussion
AI cannot always maintain logical coherence between methodology, findings, and discussion. Disconnections between sections can undermine a manuscript's scientific credibility.
Risk of Fabricated Sources
Artificial intelligence tools can generate non-existent sources or incorrect citations. The use of unverified sources poses a serious risk to academic credibility and must be thoroughly checked.
This is Not an "AI Detection" Issue, but an Academic Quality Concern
The core issue is not detecting whether a text was generated by AI, but rather its scientific depth, coherence, and accuracy. When uncontrolled AI use diminishes this quality, the rejection risk increases not "due to AI" alone, but due to a lack of academic quality.
Common Mistakes
- Using AI-generated text without oversight
- Adding sources without verification
- Failing to check methodological consistency
- Skipping context-specific evaluation
The Right Approach: Human Expert Oversight
While artificial intelligence can be an accelerating tool, scientific responsibility ultimately rests with the human expert. Every text must be reviewed for methodology, sources, and consistency.
How msCRO Positions Itself in This Process
msCRO utilizes artificial intelligence tools under expert supervision, in a way that strengthens academic quality. Under no circumstances are uncontrolled, unreviewed AI outputs incorporated into the scientific process.
Conclusion
Uncontrolled use of artificial intelligence can negatively impact the publication process due to academic quality issues. Expert oversight is the primary way to mitigate these risks.
You can initiate a preliminary evaluation process with msCRO for the design, data management, and analysis phases of your clinical research.